(Q81281786)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16193240%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

title

Phase I trial of oral talactoferrin alfa in refractory solid tumors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16193240%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

main subject

phase I clinical trial

1 reference

Teresa G Hayes

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16193240%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Gerald F Falchook

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16193240%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Gauri R Varadhachary

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16193240%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Dori P Smith

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16193240%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Lisa D Davis

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16193240%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Hari M Dhingra

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16193240%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Benjamin P Hayes

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16193240%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Atul Varadhachary

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16193240%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

publication date

1 May 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16193240%20AND%20SRC:MED&resulttype=core&format=json

Investigational New Drugs

7 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16193240%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16193240%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16193240%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

233-240

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16193240%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10637-005-3690-6

7 January 2020

exact match

0 references

cites work

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

12 December 2020

Oral lactoferrin inhibits growth of established tumors and potentiates conventional chemotherapy.

1 reference

12 December 2020

A randomised trial of cisplatin and vindesine versus supportive care only in advanced non-small cell lung cancer

1 reference

12 December 2020

Secretory responses of human neutrophils: exocytosis of specific (secondary) granules by human neutrophils during adherence in vitro and during exudation in vivo

1 reference

12 December 2020

Is Gompertzian or exponential kinetics a valid description of individual human cancer growth?

1 reference

12 December 2020

Lactoferrin and its biological functions.

1 reference

12 December 2020

The universal dynamics of tumor growth

1 reference

12 December 2020

A randomized trial of alternating chemotherapy versus best supportive care in advanced non-small-cell lung cancer

1 reference

12 December 2020

Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy.

1 reference

12 December 2020

Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin

1 reference

12 December 2020

Long-term follow-up of chronic hepatitis C patients treated with oral lactoferrin for 12 months

1 reference

12 December 2020

Isolation and function of a receptor for human lactoferrin in human fetal intestinal brush-border membranes

1 reference

12 December 2020

Influence of Lactoferrin on the Function of Human Polymorphonuclear Leukocytes and Monocytes

1 reference

12 December 2020

Monocyte and NK cell cytotoxic activity in human adherent cell preparations: discriminating effects of interferon and lactoferrin

1 reference

12 December 2020

A system for production of commercial quantities of human lactoferrin: a broad spectrum natural antibiotic

1 reference

12 December 2020

Phase II clinical trial design for noncytotoxic anticancer agents for which time to disease progression is the primary endpoint.

1 reference

12 December 2020

Recombinant human lactoferrin ingestion attenuates indomethacin-induced enteropathy in vivo in healthy volunteers

1 reference

12 December 2020

Lactoferrin: a multifunctional glycoprotein

1 reference

12 December 2020

Lactotransferrin receptor of mouse small-intestinal brush border. Binding characteristics of membrane-bound and triton X-100-solubilized forms

1 reference

12 December 2020

Cancer prevention by bovine lactoferrin and underlying mechanisms--a review of experimental and clinical studies

1 reference

12 December 2020